Story Stocks^®

Centene’s (CNC) 2Q25 earnings report underscored the intense pressures facing the health insurance industry as the company fell short of EPS expectations and slashed its FY25 EPS guidance to $1.75 from its prior guidance of $7.25. Despite the troubling results and outlook, CNC's stock is climbing higher amid a relief rally as the market had already priced in much of the negative sentiment following the company’s July 1 withdrawal of its 2025 guidance. That withdrawal triggered a 40% stock price plunge after Wakely’s industry data revealed higher-than-expected morbidity and lower Marketplace growth.

This followed similar moves by peers, with UnitedHealth (UNH) suspending its FY25 outlook in May due to rising Medicare Advantage costs and Molina Healthcare (MOH) slashing its 2025 EPS forecast on July 9, citing elevated medical costs and unpredictable utilization trends, setting rock-bottom expectations for CNC’s Q2 report.

• CNC's Health Benefits Ratio surged to 93.0% in Q2 from 87.6% a year earlier, reflecting significant margin compression driven by multiple factors. Higher medical costs in the Marketplace segment stemmed from increased acuity among enrollees, particularly in behavioral health and high-cost specialty drugs, while Medicaid faced similar pressures from rising costs in behavioral health, home health, and pharmaceuticals, especially in key states like New York and Florida.
• Additionally, a $1.8 bln reduction in CNC’s 2025 net Marketplace risk adjustment revenue transfer estimate, later revised to $2.4 bln, exacerbated the HBR spike, as the sicker-than-expected patient pool disrupted risk adjustment assumptions, leading to lower federal reimbursements.
• Membership trends showed contraction in CNC’s core government-backed programs, with Medicaid membership declining to 12.82 mln from 13.1 mln yr/yr, primarily due to post-pandemic eligibility redeterminations that reduced enrollment, particularly in states with stricter recertification processes. Medicare membership also fell to 1.03 mln from 1.13 mln, driven by competitive pressures in Medicare Advantage and adjustments following the Inflation Reduction Act’s impact on Part D plans.
• In contrast, the Commercial segment, particularly the ACA Marketplace under the Ambetter brand, was a bright spot, with membership growing to 6.3 mln from 4.8 mln, fueled by strong demand for affordable plans despite the higher morbidity challenges impacting profitability.
• The slashed FY25 EPS guidance reflects a significant $2.4 bln revenue headwind, up from an earlier $1.8 bln estimate, driven by worse-than-expected Marketplace morbidity, with market morbidity raising by 16-17% yr/yr in some states. This shift, identified through Wakely’s data, suggests higher-risk patients are enrolling, increasing medical costs and reducing risk adjustment transfers. Elevated utilization trends, particularly in behavioral health and chronic condition management, are also noted as key drivers, with an additional $200 mln pre-tax headwind expected in 2H25 due to sustained high medical costs.
• CNC has fortified its platform to navigate the turbulent environment, leveraging its scale as the largest ACA Marketplace carrier with 4.4 mln members and a diversified presence across Medicaid, Medicare, and Commercial segments. The company is actively refiling 2026 Marketplace rates to reflect higher morbidity baselines and negotiating with states to align Medicaid reimbursements with rising acuity, aiming to stabilize margins. Operational efficiencies, cost-saving initiatives, and growth in Medicare Advantage, which performed better than expected, should position CNC for a potential recovery once these headwinds ease.

The health insurance industry is grappling with unprecedented medical cost pressures and shifting risk pools, and CNC’s Q2 results and slashed FY25 outlook reflect these systemic challenges. While the company’s diversified platform and proactive rate adjustments offer a path to recovery, near-term profitability remains constrained by elevated morbidity and utilization trends.